Niagen Bioscience
NAGE
139 hedge funds and large institutions have $172M invested in Niagen Bioscience in 2025 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 49 increasing their positions, 33 reducing their positions, and 15 closing their positions.
1,185% more call options, than puts
Call options by funds: $1.89M | Put options by funds: $147K
127% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 15
48% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 33
44% more capital invested
Capital invested by funds: $119M → $172M (+$52.7M)
13% more funds holding
Funds holding: 123 → 139 (+16)
2.58% more ownership
Funds ownership: 29.44% → 32.02% (+2.6%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$2.36M |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$2.28M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$2.11M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.07M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$2.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Iconiq Capital
San Francisco,
California
|
-$4.47M |
| 2 |
TCM
Tieton Capital Management
Yakima,
Washington
|
-$3.79M |
| 3 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$1.65M |
| 4 |
Renaissance Technologies
New York
|
-$1.19M |
| 5 |
Los Angeles Capital Management
Los Angeles,
California
|
-$601K |
NAGE Hedge Fund Activity: Q1 2025 in Review
139 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Niagen Bioscience (NAGE) for Q1 2025, worth a combined $172M — up 44% from $119M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new NAGE positions and 15 closed out — a net gain of 19 holders — while 49 added to existing stakes and 33 trimmed.
The largest buyer was Millennium Management, adding an estimated $2.36M. The largest seller was Iconiq Capital, cutting an estimated $4.47M.
- 139 institutional investors held Niagen Bioscience (NAGE) as of Q1 2025, up from 123 in Q4 2024.
- Funds reported $172M of Niagen Bioscience stock for Q1 2025, up 44% quarter-over-quarter.
- 34 funds opened new Niagen Bioscience positions in Q1 2025 and 15 closed out, a net change of +19 holders.
- The largest Niagen Bioscience buyer in Q1 2025 was Millennium Management, an estimated $2.36M added.
- The largest Niagen Bioscience seller in Q1 2025 was Iconiq Capital, an estimated $4.47M sold.
Based on aggregated 13F filings for Q1 2025.